Idorsia (IDRSF) News Today

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)

$2.03

0.00 (0.00%)

(As of 04/18/2024 ET)

Stock Analysis Analyst Forecasts Chart Headlines Short Interest

Source

Source	Headline
	Idorsia publishes a Financial Status required for an upcoming bondholder meeting finance.yahoo.com - April 17 at 9:18 AM
	Idorsia Ltd (OTCMKTS:IDRSF) Short Interest Down 7.6% in March americanbankingnews.com - April 17 at 1:08 AM
	Idorsia takes steps to address short-term liquidity needs globenewswire.com - April 11 at 1:00 AM
	Idorsia gets FDA approval for high blood pressure drug Tryvio bizjournals.com - March 22 at 4:16 PM
	Idorsia: Aprocitentan Approval Is A Vital News seekingalpha.com - March 22 at 4:16 PM
	Idorsia thanks Guy Braunstein for his years of service as he retires globenewswire.com - March 22 at 2:00 AM
	FDA approves Idorsia’s once-daily antihypertensive Tryvio msn.com - March 20 at 9:47 PM
	Idorsia gets FDA approval for hypertension drug Tryvio msn.com - March 20 at 4:44 PM
	Idorsia Ltd (IDRSF) Stock Historical Prices & Data - Yahoo Finance finance.yahoo.com - March 20 at 11:44 AM
	US FDA approves Idorsia's once-daily TRYVIO (aprocitentan) – the first and only endothelin receptor antagonist for the treatment of high blood pressure not adequately controlled in combination with other antihypertensives globenewswire.com - March 20 at 2:00 AM
	What Does The Future Hold For Idorsia Ltd (VTX:IDIA)? These Analysts Have Been Cutting Their Estimates finance.yahoo.com - March 8 at 1:45 AM
	Kepler Cheuvreux gets more bullish on Idorsia, upgrades shares realmoney.thestreet.com - March 7 at 10:44 AM
	Viatris, Idorsia Announce Global Research And Development Collaboration markets.businessinsider.com - February 28 at 2:21 AM
	Here's what to expect from Idorsia's earnings markets.businessinsider.com - February 6 at 3:28 PM
	Idorsia presents at the J.P. Morgan Healthcare Conference – Adapting Idorsia for sustainable value creation finance.yahoo.com - January 10 at 6:58 AM
	Idorsia Ltd (VTX:IDIA) surges 19%; individual investors who own 41% shares profited along with insiders finance.yahoo.com - December 6 at 9:15 AM
	Idorsia Q3 Review: Not The Quarter We Expected msn.com - October 25 at 10:07 AM
	Idorsia GAAP EPS of CHF0.96, revenue of CHF80M msn.com - October 24 at 1:12 PM
	Idorsia announces financial results for the first nine months of 2023 – adapting the company to create sustainable value finance.yahoo.com - October 24 at 8:12 AM
	Idorsia Shares Fall on Funding Needs marketwatch.com - October 24 at 8:12 AM
	Idorsia is committed to further the science of sleep with a symposium and poster presentations at World Sleep 2023 finance.yahoo.com - October 23 at 9:40 AM
	NICE recommends Idorsia’s chronic insomnia treatment for UK patients msn.com - September 15 at 3:51 PM
	Idorsia reacquires the world-wide rights to aprocitentan uk.finance.yahoo.com - September 6 at 4:53 AM
	Tausif ('Tosh') Butt to Join Idorsia Pharmaceuticals U.S. as President and General Manager finance.yahoo.com - August 31 at 6:40 PM
	Idorsia Ltd (IDIA.SW) finance.yahoo.com - August 25 at 10:55 PM
	Are Investors Undervaluing Idorsia Ltd (VTX:IDIA) By 38%? uk.finance.yahoo.com - August 18 at 4:58 PM
	Idorsia: Restructuring In Place msn.com - July 27 at 4:01 AM
	Analysts Have Just Cut Their Idorsia Ltd (VTX:IDIA) Revenue Estimates By 21% finance.yahoo.com - July 27 at 4:01 AM
	Idorsia announces financial results for the first half 2023 – adapting the company to create sustainable value finance.yahoo.com - July 25 at 10:59 AM
	Idorsia Shares Plunge After Suspension of 2025 Profitability Target marketwatch.com - July 25 at 10:59 AM
	Idorsia announces a cost reduction initiative to be implemented by the end of 2023 finance.yahoo.com - July 21 at 9:42 AM
	UPDATE 2-Japan's Sosei buys Idorsia Pharma's Japan, Korea units for $466 mln jp.reuters.com - July 20 at 11:34 PM
	Sosei Heptares - Investor and Press Conference on Today's Announcement Regarding the Acquisition and License Transaction with Idorsia benzinga.com - July 20 at 8:33 AM
	Idorsia announces its insomnia medication, QUVIVIQ (daridorexant), is now covered by CVS finance.yahoo.com - July 10 at 7:23 AM
	Idorsia Pharmaceuticals Ltd: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2023 finanznachrichten.de - June 25 at 11:57 PM
	Idorsia has secured bridge financing in the amount of CHF 75 million finance.yahoo.com - June 20 at 2:59 AM
	Idorsia: Dilution Risk Causes Downgrade To Hold msn.com - June 10 at 2:06 PM
	Idorsia in talks about potential $440M Asia Pacific licensing deal bizjournals.com - June 6 at 1:32 PM
	Investors in Idorsia (VTX:IDIA) have unfortunately lost 71% over the last three years finance.yahoo.com - June 2 at 8:45 AM
	Idorsia announces a change to commercial leadership finance.yahoo.com - May 30 at 7:25 PM
	Idorsia (SIX:IDIA) Price Target Decreased by 7.89% to 14.26 msn.com - May 11 at 10:00 PM
	Health Canada approves QUVIVIQ (daridorexant) for the management of adult patients with insomnia finance.yahoo.com - May 7 at 1:49 PM
	Getting In Cheap On Idorsia Ltd (VTX:IDIA) Might Be Difficult uk.finance.yahoo.com - May 6 at 9:56 AM
	Invitation to Idorsia's Q1 2023 Financial Results webcast and conference call uk.finance.yahoo.com - April 18 at 8:42 PM
	Idorsia Pharmaceuticals files citizens petition with DEA seeking to de-schedule its insomnia drug Quviviq bizjournals.com - April 9 at 5:44 PM
	Idorsia Pharmaceuticals Ltd: Idorsia issues invitation to the 2023 Annual General Meeting of Shareholders finanznachrichten.de - April 6 at 10:47 AM
	Idorsia issues invitation to the 2023 Annual General Meeting of Shareholders finance.yahoo.com - April 6 at 10:47 AM
	On World Sleep Day Idorsia highlights the publication of a global study on the economic and societal impact of chronic insomnia disorder finance.yahoo.com - March 17 at 10:14 PM
	Idorsia Ltd (VTX:IDIA) Just Reported And Analysts Have Been Cutting Their Estimates yahoo.com - February 9 at 5:47 AM
	Idorsia announces financial results for 2022 – building momentum to become a leading mid-sized biopharmaceutical company uk.finance.yahoo.com - February 7 at 10:52 AM

Get Idorsia News Delivered to You Automatically

New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

IDRSF Media Mentions By Week

IDRSF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IDRSF
News Sentiment
▼
0.25

0.53
▲
Average
Medical
News Sentiment

IDRSF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IDRSF Articles
This Week
▼
2

0
▲
IDRSF Articles
Average Week

Get Idorsia News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (OTCMKTS:IDRSF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Idorsia (IDRSF) News Today

IDRSF Media Mentions By Week

IDRSF Media Sentiment

IDRSF News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info